We reported the global Ikaros binding profile in ALL [33], and found the apparent binding peaks in promoter regions of BCL6 and BACH2 in B-ALL patients using ChIP-seq data. This evidence concerns the gene BCL6 and precursor B-cell acute lymphoblastic leukemia.